Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazushige Sakaguchi is active.

Publication


Featured researches published by Kazushige Sakaguchi.


Genomics | 1989

Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11

Sherri J. Bale; Allen E. Bale; Karen Stewart; Laura Dachowski; O.W. McBride; Tom Glaser; Joseph Green; John J. Mulvihill; Maria Luisa Brandi; Kazushige Sakaguchi; G. D. Aurbach; Stephen J. Marx

We evaluated linkage between the locus for multiple endocrine neoplasia type 1 (MEN1) and several polymorphic DNA markers on chromosome 11 in a single large pedigree. On the basis of the finding of a basic fibroblast growth factor (bFGF)-like substance circulating in plasma of MEN1 patients, we chose a bFGF-related gene known to be localized to 11q13 as one of the markers. This gene locus, INT2, was found to be closely linked to the MEN1 gene. Pairwise and multipoint analyses with INT2 confirm the recent finding by C. Larsson et al. (1988, Nature (London) 332: 85-87) of MEN1 linkage to another marker, skeletal muscle glycogen phosphorylase, at 11q13.


Biochemical and Biophysical Research Communications | 1989

Clonal rat parathyroid cell line expresses a parathyroid hormone-related peptide but not parathyroid hormone itself

Kyoji Ikeda; Eleanor C. Weir; Kazushige Sakaguchi; William J. Burtis; Mark B. Zimering; Marguerite Mangin; Barbara E. Dreyer; Maria Luisa Brandi; G. D. Aurbach; Arthur E. Broadus

A novel parathyroid hormone-related peptide has been identified in tumors associated with the syndrome of humoral hypercalcemia of malignancy. Subsequently, mRNAs encoding this peptide have been found to be expressed in a number of normal tissues, including the parathyroids. Using Northern blotting, RNase protection, and immunochemical techniques, we examined a clonal rat parathyroid cell line originally developed as a model system for studying parathyroid cell physiology. We found that this line expresses the parathyroid hormone-related peptide but not parathyroid hormone itself. Secretion of the parathyroid hormone-related peptide varied inversely with extracellular calcium concentration, but neither calcium nor 1,25-dihydroxyvitamin D3 appeared to influence steady-state parathyroid hormone-related peptide mRNA levels. This clonal line may prove to be an interesting system for studying the factors responsible for tissue-specific parathyroid hormone and parathyroid hormone-related peptide gene expression.


Journal of Biological Chemistry | 2007

Regulation of Ephexin1, a Guanine Nucleotide Exchange Factor of Rho Family GTPases, by Fibroblast Growth Factor Receptor-mediated Tyrosine Phosphorylation

Yueqiang Zhang; Takahiro Sawada; Xuefeng Jing; Hideyuki Yokote; Xiaomei Yan; Kazushige Sakaguchi

Fibroblast growth factor (FGF) signal is implicated in not only cell proliferation, but cell migration and morphological changes. Several different Rho family GTPases downstream of the Ras/ERK pathway are postulated to mediate the latter functions. However, none have been recognized to be directly coupled to FGF receptors (FGFRs). We have previously reported that EphA4 and FGFRs hetero-oligomerize through their cytoplasmic domains, trans-activate each other, and transduce a signal for cell proliferation through a docking protein, FRS2α (Yokote, H., Fujita, K., Jing, X., Sawada, T., Liang, S., Yao, L., Yan, X., Zhang, Y., Schlessinger, J., and Sakaguchi, K. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 18866-18871). Here, we have found that ephexin1, a guanine nucleotide exchange factor for Rho family GTPases, constitutes another downstream component of the receptor complex. Ephexin1 directly binds to the kinase domain of FGFR mainly through its DH and PH domains. The binding appears to become weaker and limited to the DH domain when FGFRs become activated. FGFR-mediated phosphorylation of ephexin1 enhances the guanine nucleotide exchange activity toward RhoA without affecting the activity to Rac1 or Cdc42. The FGFR-mediated tyrosine phosphorylation includes, but is not limited to, the residue (Tyr-87) phosphorylated by Src family kinase, which is known to be activated following EphA4 activation. The Tyr-to-Asp mutations that mimic the tyrosine phosphorylation in some of the putative FGFR-mediated phosphorylation sites increase the nucleotide exchange activity for RhoA without changing the activity for Rac1 or Cdc42. From these results, we conclude that ephexin1 is located immediately downstream of the EphA4-FGFR complex and the function is altered by the FGFR-mediated tyrosine phosphorylation at multiple sites.


Molecular and Cellular Biology | 1999

The Acidic Domain and First Immunoglobulin-Like Loop of Fibroblast Growth Factor Receptor 2 Modulate Downstream Signaling through Glycosaminoglycan Modification

Kazushige Sakaguchi; Matthew V. Lorenzi; Donald P. Bottaro; Toru Miki

ABSTRACT Fibroblast growth factor receptors (FGFRs) are membrane-spanning tyrosine kinases that have been implicated in a variety of biological processes including mitogenesis, cell migration, development, and differentiation. We identified a unique isoform of FGFR2 expressed as a diffuse band with an unusually large molecular mass. This receptor is modified by glycosaminoglycan at a Ser residue located immediately N terminal to the acidic box, a stretch of acidic amino acids. The acidic box and the glycosaminoglycan modification site are encoded by an alternative exon of the FGFR2 gene. The acidic box appears to play an important role in glycosaminoglycan modification, and the presence of this domain is required for modification by heparan sulfate glycosaminoglycan. Moreover, the presence of the first immunoglobulin-like domain encoded by another alternative exon abrogated the modification. The high-affinity receptor with heparan sulfate modification enhanced receptor autophosphorylation, substrate phosphorylation, and ternary complex factor-independent gene expression. It also sustained mitogen-activated protein kinase activity and increased eventual DNA synthesis, a long-term response to fibroblast growth factor stimulation, at physiological ligand concentrations. We propose a novel regulation mechanism of FGFR2 signal transduction through glycosaminoglycan modification.


Oncogene | 1999

Identification of a novel activated form of the keratinocyte growth factor receptor by expression cloning from parathyroid adenoma tissue.

Kazushige Sakaguchi; Matthew V. Lorenzi; Hiroshi Matsushita; Toru Miki

Parathyroid adenomas are benign tumors in the parathyroid glands, whose pathogenesis is largely unknown. We utilized an expression cDNA cloning strategy to identify oncogenes activated in parathyroid adenomas. An expression cDNA library was prepared directly from a clinical sample of parathyroid adenoma tissue, transfected into NIH3T3 cells, and foci of morphologically transformed cells were isolated. Following plasmid rescue, we identified cDNAs for the keratinocyte growth factor receptor at a high frequency. Interestingly, approximately half of the clones encoded a variant receptor containing an altered C-terminus. Analysis of the transforming activity of the variant receptor revealed that the altered C-terminus up-regulated the transforming activity in a ligand-independent manner. The higher transforming activity was not accompanied by increase of dimerization or overall autophosphorylation of the receptor. However, tyrosine phosphorylation of downstream receptor substrates, including Shc isoforms and possibly FRS2, are increased in the transfectants expressing the parathyroid tumor-derived receptor. Genomic analysis showed that a previously unidentified exon was used to form the novel isoform. This alternative splicing appears to occur preferentially in parathyroid adenomas.


PLOS ONE | 2015

Trans-Activation between EphA and FGFR Regulates Self-Renewal and Differentiation of Mouse Embryonic Neural Stem/Progenitor Cells via Differential Activation of FRS2α.

Takahiro Sawada; Daiki Arai; Xuefeng Jing; Kenryo Furushima; Qingfa Chen; Kazuki Kawakami; Hideyuki Yokote; Masayasu Miyajima; Kazushige Sakaguchi

Ephs and FGFRs belong to a superfamily of receptor tyrosine kinases, playing important roles in stem cell biology. We previously reported that EphA4 and FGFR form a heterodimer following stimulation with ligands, trans-activating each other and signaling through a docking protein, FRS2α, that binds to both receptors. Here, we investigated whether the interaction between EphA4 and FGFRs can be generalized to other Ephs and FGFRs, and, in addition, examined the downstream signal mediating their function in embryonic neural stem/progenitor cells. We revealed that various Ephs and FGFRs interact with each other through similar molecular domains. When neural stem/progenitor cells were stimulated with FGF2 and ephrin-A1, the signal transduced from the EphA4/FGFR/FRS2α complex enhanced self-renewal, while stimulation with ephrin-A1 alone induced neuronal differentiation. The downstream signal required for neuronal differentiation appears to be MAP kinase mainly linked to the Ras family of G proteins. MAP kinase activation was delayed and sustained, distinct from the transient activation induced by FGF2. Interestingly, this effect on neuronal differentiation required the presence of FGFRs. Specific FGFR inhibitor almost completely abolished the function of ephrin-A1 stimulation. These findings suggest that the ternary complex of EphA, FGFR and FRS2α formed by ligand stimulation regulates self-renewal and differentiation of mouse embryonic neural stem/progenitor cells by ligand-specific fine tuning of the downstream signal via FRS2α.


Journal of Neurorestoratology | 2017

Direct interaction of receptor tyrosine kinases, EphA4 and PDGFRβ, plays an important role in the proliferation of neural stem cells

Qingfa Chen; Takahiro Sawada; Kazushige Sakaguchi; Fabin Han

php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Journal of Neurorestoratology 2017:5 133–141 Journal of Neurorestoratology Dovepress


The New England Journal of Medicine | 1989

Clonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1

Eitan Friedman; Kazushige Sakaguchi; Allen E. Bale; Alberto Falchetti; Elizabeth Streeten; Mark B. Zimering; Lee S. Weinstein; Wesley O. McBride; Yusuke Nakamura; Maria Luisa Brandi; Jeffrey A. Norton; G. D. Aurbach; Allen M. Spiegel; Stephen J. Marx


Proceedings of the National Academy of Sciences of the United States of America | 1994

Molecular interactions between interferon consensus sequence binding protein and members of the interferon regulatory factor family

C Bovolenta; Paul H. Driggers; Michael S. Marks; Jeffrey A. Medin; A D Politis; Stefanie N. Vogel; David E. Levy; Kazushige Sakaguchi; Ettore Appella; John E. Coligan


Journal of Biological Chemistry | 1997

Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms HEPARAN SULFATE GLYCOSAMINOGLYCAN REQUIREMENT FOR Met BINDING AND SIGNALING

Hiromi Sakata; Stephen J. Stahl; William G. Taylor; Jared M. Rosenberg; Kazushige Sakaguchi; Paul T. Wingfield; Jeffrey S. Rubin

Collaboration


Dive into the Kazushige Sakaguchi's collaboration.

Top Co-Authors

Avatar

G. D. Aurbach

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Maria Luisa Brandi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Stephen J. Marx

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Masaki Yanagishita

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar

Toru Miki

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Takahiro Sawada

Wakayama Medical University

View shared research outputs
Top Co-Authors

Avatar

Allen E. Bale

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mark B. Zimering

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Hideyuki Yokote

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge